Yun Zhisheng (09678) signed a number of major model projects for the top three hospitals

Zhitong Finance App News, Yun Zhisheng (09678) announced that following the official release of the next-generation general base U2 model, the comprehensive capabilities of the company's underlying general model have been improved by leaps and bounds, significantly accelerating model iteration efficiency in the vertical field. Recently, relying on the company's medical industry data assets accumulated over many years, combined with a deep understanding of various medical business scenarios, the company released the industry's first “U2-Med Medical University Model”, which is a major professional model for the medical, medical insurance (including commercial insurance), and pharmaceutical fields.

With the above competitive advantages, recently, the company has successively won a number of artificial intelligence medical construction projects for the top three hospitals in China, covering regional benchmark medical institutions such as Beijing You'an Hospital affiliated to Capital Medical University, the Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), and Nanjing Tongren Hospital. The implementation of these benchmark projects not only enabled the company to continue to consolidate its core competitive advantage in high-end market competition, but also marked the commercialization of the company's medical model into a new stage of large-scale replication. The series of landing orders fully confirms that the company's large-scale medical model has formed a mature, complete, standardized and large-scale delivery system that can be quickly replicated on a large scale. It can quickly adapt to the intelligent construction needs of different departments and types of hospitals, and set a benchmark example for the commercial implementation of domestic large-scale medical models.

In the future, the company will continue to deepen the application and innovation of big models in the pan-medical field, release high token industrial value based on self-developed AI core technology base, and promote the upgrading of the big medical model to industrial infrastructure. At the same time, the company will further enhance standardized and large-scale delivery capabilities, help medical institutions improve quality and efficiency, and consolidate the company's leading position in the commercialization of large-scale medical models.